Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
Virchows Archiv : an International Journal of Pathology|July 13, 2021
Basic principles of biobanking: from biological samples to precision medicine for patientsLaura Annaratone, Giuseppe De Palma, Giuseppina Bonizzi, et al.
Tumori|May 5, 2020
Response of a comprehensive cancer center to the COVID-19 pandemic: the experience of the Fondazione IRCCS-Istituto Nazionale dei Tumori di MilanoFranco Valenza, Gabriele Papagni, Alfonso Marchianò, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 26, 2024
Fenretinide in Young Women at Genetic or Familial Risk of Breast Cancer: A Placebo-Controlled Biomarker TrialValentina Aristarco, Davide Serrano, Patrick Maisonneuve, et al.
Science Translational Medicine|July 24, 2015
Optimizing sharing of hospital biobank samplesPeter H J Riegman, Bas de Jong, Maria Grazia Daidone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2019
Plasma miRNA Levels for Predicting Therapeutic Response to Neoadjuvant Treatment in HER2-positive Breast Cancer: Results from the NeoALTTO TrialSerena Di Cosimo, Valentina Appierto, Sara Pizzamiglio, et al.
Oncotarget|July 8, 2016
Anaplastic lymphoma kinase aberrations correlate with metastatic features in pediatric rhabdomyosarcomaPatrizia Gasparini, Michela Casanova, Raffaella Villa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2021
Integrated Molecular and Immune Phenotype of HER2-Positive Breast Cancer and Response to Neoadjuvant Therapy: A NeoALTTO Exploratory AnalysisSara Pizzamiglio, Chiara Maura Ciniselli, Tiziana Triulzi, et al.
Cancer Medicine|December 18, 2021
What if the future of HER2-positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO studySara Pizzamiglio, Giulia Cosentino, Chiara M Ciniselli, et al.
European Journal of Cancer (Oxford, England : 1990)|July 9, 2019
The 41-gene classifier TRAR predicts response of HER2 positive breast cancer patients in the NeoALTTO studySerena Di Cosimo, Tiziana Triulzi, Sara Pizzamiglio, et al.
Endocrine|June 23, 2026
Liquid biopsies for BRAF V600E assessment and monitoring in anaplastic thyroid carcinoma: a real-world study of a tertiary cancer centerElena Colombo, Elisa Ortolan, Stefano Cavalieri, et al.
Pageof 14